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Background: Atrial fibrillation is the most common arrhythmia after cardiac surgery. Several studies have shown increased in-hospital mortality 
(IHM), while few others have shown increased long term mortality related to new onset atrial fibrillation (NAF) after cardiac surgery. Association 
between mortality and NAF is based on single institution studies and is not well established.
Methods: We performed a meta-analysis of cohort studies evaluating association between NAF and short (30 dayor IHM) and long term mortality 
(> 6 months upto 4 years) and the risk factors associated with incident NAF after cardiac surgery. Three investigators conducted independent 
literature searches between 1960 till October 2008. We excluded studies involving atrial flutter and tachycardia, off-pump coronary artery bypass 
graft (CABG) and isolated valve surgery. Random effects models were used to account for heterogeneity among the studies.
Results: Approximately 1% of the studies (10 studies; n=39,496) met the selection criteria. 93% of patients (mean age 65 years, 75% male) 
underwent CABG only. All studies evaluated IHM and 4 studies also evaluated long term mortality. NAF was associated with higher risk of short-term 
mortality (3.6% vs 2% OR 2.11; CI[1.58-2.81], p< 0.00001); heterogeneity of effects was significant (p=0.0007). Risks for 6 months and 1 year 
mortality were (2.66 [1.95-3.65] and 2.51[2.06-3.07], respectively. Higher age, lower ejection fraction, and history of hypertension, stroke, heart 
failure and peripheral artery disease were strongly associated with NAF. Preoperative use of beta-blockers limitedly reduced the risk of NAF(OR 
0.94[0.88-1.01]). Use of ACE inhibitors was associated with an increased risk of NAF(OR 1.20[1.11-1.29] p<0.00001.Longer cardio-pulmonary 
bypass (CPB) and aortic clamp times and use of intra-aortic balloon pump (IABP) were also associated with NAF.
Conclusions: NAF increases short and long term mortality in patients undergoing CABG. Among the modifiable factors use of beta-blockers 
was associated with decreased incidence of NAF whileas use of ACE inhibitors, IABP, longer CPB and aortic clamp times were all associated with 
increased incidence of NAF.
